Li, K., Jin, J., Yang, J., Li, Y., Zhao, W., Luo, G., . . . Huang, F. (2018). Full dose, half dose, or discontinuation of etanercept biosimilar in early axial spondyloarthritis patients: A real-world study in China. Arch Med Sci.
Styl cytowania ChicagoLi, Kun-Peng, Jing-Yu Jin, Jin-Shui Yang, Yan Li, Wei Zhao, Gui Luo, Jian Zhu, Jiang-Lin Zhang, i Feng Huang. "Full Dose, Half Dose, or Discontinuation of Etanercept Biosimilar in Early Axial Spondyloarthritis Patients: A Real-world Study in China." Arch Med Sci 2018.
Styl cytowania MLALi, Kun-Peng, et al. "Full Dose, Half Dose, or Discontinuation of Etanercept Biosimilar in Early Axial Spondyloarthritis Patients: A Real-world Study in China." Arch Med Sci 2018.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..